26 July 2021 | Monday | News
Collaborative Drug Discovery, Inc. (CDD), provider of the web-based drug discovery informatics platform CDD Vault, announces the launch of a new data offering named BioHarmony. BioHarmony provides semantically curated live feeds of drug data from diverse sources.
Often researchers may focus too narrowly on one aspect of a problem, however by culling data from pre-clinical, clinical, and post approval sources, researchers can now glean new insights from their models. BioHarmony combines up-to-the-date data connected to their respective underlying sources on the rapidly evolving semantic web. Having a centralized and standardized data format better informs models whether with public and/or private data streams.
Semantic data feeds on Top Revenue Generating Drugs as well as subsidized information on potential COVID-19 repurposed drugs are now available via online subscription in the BioHarmony Content Store. All data can be exported from the application at any time in both computer-readable (JSON) and human readable (CSV, XLSX) formats. The content is updated regularly and triple checked for accuracy. Requests for new feeds are available "On-Demand" for any individual drug or sets of drugs for comparison studies.